BLKB · Blackbaud, Inc.

The thesis

Blackbaud's recovery from the late-September low is intact but unproven: the shares closed at $44.84 on 8 October 2026, up from $43.19 on 25 September 2026, and the third-quarter report due around 28 October 2026 settles whether organic growth holds at the 3.0% reported for the second quarter. The case rests on a software business with 98.2% recurring revenue and a large buyback authorization; it weakens if organic growth slips or the 2026 revenue guide is cut.

The narrative is maturing: the story is well known, and the main new item since the last note is the 29 September 2026 partnership with BILL, which gives no revenue figure. The shares are 34.0% below the 52-week high of $67.95 and 44.5% above their level three months ago, so the rebound is large against a depressed starting point.

Bullish and bearish views on Blackbaud, Inc.

The bull case on Blackbaud, Inc. (BLKB), in brief: Recurring revenue gives visibility. The bear case: Growth is modest.

Bull case

• Recurring revenue gives visibility. Blackbaud reported Q2 2026 recurring revenue of $285.3 million, 98.2% of total revenue, on 29 July 2026. Organic revenue grew 3.0% year over year. Q2 results
• Buyback capacity is large. Blackbaud had approximately $850 million left under its repurchase authorization at 30 June 2026 and said it had repurchased just over 6% of shares year to date. The company pays no dividend, so repurchases are the main cash return.
• Guidance was held. On 29 July 2026 Blackbaud reaffirmed 2026 revenue guidance of $1.173 billion–$1.179 billion and non-GAAP diluted earnings per share of $5.15–$5.25. Benzinga showed the revenue range bracketing the $1.176 billion analyst estimate and the earnings range bracketing the $5.19 estimate.
• Analysts have nudged targets up. Evercore ISI kept an In-Line rating and raised its target to $48 on 30 July 2026. Baird kept Outperform and raised its target from $54 to $58 on 15 September 2026, per Benzinga.
• A new distribution channel opened. Blackbaud and BILL announced a strategic partnership on 29 September 2026 to simplify accounts payable for nonprofit and education finance teams. No revenue contribution was disclosed.

Bear case

• Growth is modest. Q2 2026 organic revenue growth was 3.0%. A Q3 rate below that would contradict the recovery argument.
• The beat came from earnings, not sales.
• The late-September low was below prior support. The shares closed at $43.19 on 25 September 2026 with a 14-day relative strength index of 30.0. The index has since risen to 61.0 as of 8 October 2026, so the low has been tested only once.
• Analyst targets cluster near the price. Evercore ISI's $48 target sits about 7% above the 8 October 2026 close. Only Baird's $58 target is well above it among the targets cited here.

Price setup

The last close was $44.84 on 8 October 2026. That is 3.8% above the 25 September 2026 close of $43.19 and 34.0% below the 52-week high of $67.95 (adjusted daily closes). The 14-day relative strength index is 61.0, a neutral-to-firm reading after the 30.0 oversold reading two weeks earlier.

The $43.19 close is the nearest reference low. A daily close below it would show the September low failing a second time. A move toward the $47–$48 area would approach Evercore ISI's $48 target.

Crowding evidence is limited. The shares rose 44.5% over three months, and the quarterly report is about three weeks away, so a large move on results is plausible in either direction. No Form 4 insider-selling filings were reviewed for this note.

Catalysts, next 30 days

• ~28 October 2026, est.: Q3 2026 results. The company has not confirmed the date in sources reviewed; the Q3 2025 report came on 29 October 2025. The report tests the 3.0% organic growth rate and the $1.173 billion–$1.179 billion revenue guide.
• Before the report: Blackbaud date announcement. The company typically announces the results date in advance; the 8-K for results will be the confirming filing.

Elapsed catalysts

• Ongoing: repurchase disclosure. Q3 results should update the share count and remaining authorization from $850 million at 30 June 2026. (passed 114d ago)

What would change the view

The case breaks if Q3 organic revenue growth falls below the 3.0% reported on 29 July 2026, or if Blackbaud cuts the $1.173 billion–$1.179 billion revenue range or the $5.15–$5.25 earnings range. A weaker repurchase pace would also remove a source of demand for the shares.

On price, a daily close below $43.19, the 25 September 2026 close, would show the late-September low giving way. A Q3 report with organic growth at or above 3.0% and guidance held would strengthen the recovery case, and a rise in organic growth above that rate would be the clearest confirmation.

What it trades with

Blackbaud trades as a small-cap software company with nonprofit and education customers. Its price moves with small-cap software sentiment and interest-rate expectations more than with any single technology theme. The BILL partnership links it to nonprofit finance workflows, but no shared revenue is disclosed. Stifel-type single-analyst moves and index-wide software selloffs both showed up in the September decline; the sample is too small to isolate a cause.